Literature DB >> 23389593

Animal rule for drug approval creates a jungle of confusion.

Elie Dolgin.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 23389593     DOI： 10.1038/nm0213-118

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  3 in total

1.  Focus on sepsis.

Authors: 
Journal:  Nat Med       Date:  2012-07-06       Impact factor: 53.440

2.  Raxibacumab for the treatment of inhalational anthrax.

Authors:  Thi-Sau Migone; G Mani Subramanian; John Zhong; Letha M Healey; Al Corey; Matt Devalaraja; Larry Lo; Stephen Ullrich; Janelle Zimmerman; Andrew Chen; Maggie Lewis; Gabriel Meister; Karen Gillum; Daniel Sanford; Jason Mott; Sally D Bolmer
Journal:  N Engl J Med       Date:  2009-07-09       Impact factor: 91.245

3.  FDA Experience with Medical Countermeasures under the Animal Rule.

Authors:  Paul Aebersold
Journal:  Adv Prev Med       Date:  2011-09-20
  3 in total
  2 in total

Review 1.  Designing inhibitors of anthrax toxin.

Authors:  Ekaterina M Nestorovich; Sergey M Bezrukov
Journal:  Expert Opin Drug Discov       Date:  2014-01-22       Impact factor: 6.098

Review 2.  A treatment for and vaccine against the deadly Hendra and Nipah viruses.

Authors:  Christopher C Broder; Kai Xu; Dimitar B Nikolov; Zhongyu Zhu; Dimiter S Dimitrov; Deborah Middleton; Jackie Pallister; Thomas W Geisbert; Katharine N Bossart; Lin-Fa Wang
Journal:  Antiviral Res       Date:  2013-07-06       Impact factor: 5.970
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.